Acquire Certified CJC-1295 no DAC (Mod GRF 1-29) | Premium GHRH Analogue for Somatotropic Research
Advance Your Investigations into Growth Hormone Regulation with High-Grade CJC-1295 no DAC
Elevate your research into growth hormone release, pulsatile signaling, and metabolic regulation with our rigorously characterized CJC-1295 no DAC (Mod GRF 1-29) formulation. This synthetic growth hormone-releasing hormone (GHRH) analogue is produced under stringent cGMP guidelines within US-based facilities, ensuring exceptional purity and batch-to-batch reproducibility. We maintain ready inventory to support rapid deployment, allowing you to proceed with your experimental timelines without procurement delays.
Comprehensive Scientific Overview & Research Applications
CJC-1295 no DAC (Mod GRF 1-29) has emerged as a compound of significant interest within the fields of endocrinology, metabolic research, and growth hormone biology. This modified analogue of GHRH possesses a distinctive molecular architecture that positions it as a valuable tool for investigating hypothalamic-pituitary-somatotropic axis function, pulsatile growth hormone secretion, and downstream metabolic signaling pathways. Researchers incorporating our CJC-1295 no DAC into their protocols benefit from a well-characterized reagent that supports reproducible data acquisition. This product has been featured in a substantial body of literature exploring the molecular mechanisms underlying growth hormone regulation, metabolic homeostasis, and tissue growth.
Mechanistic Insights & Biological Context
The scientific value of CJC-1295 no DAC lies in its targeted interaction with the GHRH receptor on pituitary somatotrophs, stimulating endogenous growth hormone release in a pulsatile manner. The absence of a drug affinity complex (DAC) allows for a shorter half-life, more closely mimicking physiological growth hormone secretion patterns. Understanding its receptor binding kinetics and downstream effects on somatotropic signaling is essential for rigorous experimental design in endocrine research. By selecting our preparation, investigators can confidently examine these molecular interactions with a compound that remains free from cross-reactive impurities that could compromise data integrity.
Comprehensive Product Specifications
| Parameter | Specification Details |
|---|---|
| Product Designation | CJC-1295 no DAC (Mod GRF 1-29) – Research Grade |
| Purity Assurance | ≥99% (HPLC-Verified with CoA) |
| Physical Presentation | Sterile Lyophilized Powder |
| Recommended Storage | Cryogenic Preservation (-20°C) |
| Primary Application | In-Vitro Laboratory Research Only |
| Manufacturing Standard | US-Produced; Full cGMP Compliance |
Why Select Our Research Solutions?
-
Independent Quality Validation: Every batch undergoes third-party HPLC analysis to confirm purity and potency, with Certificates of Analysis (CoA) included for complete quality transparency.
-
Domestic Production Infrastructure: Our manufacturing operations are entirely US-based, adhering to the most rigorous quality assurance frameworks in the peptide research industry.
-
Reliable Global Distribution: We prioritize secure, temperature-controlled packaging with expedited shipping options to ensure your CJC-1295 no DAC arrives in optimal condition, regardless of your laboratory location.
Frequently Asked Questions
Q: What is the current availability of CJC-1295 no DAC (Mod GRF 1-29)?
A: We maintain consistent inventory levels of CJC-1295 no DAC, ensuring prompt order processing and immediate dispatch for all approved research accounts.
Q: How is the purity verified for this compound?
A: Each production batch is independently tested via high-performance liquid chromatography (HPLC), confirming a minimum purity threshold of 99%, with full documentation available upon request.
Explore Our Complementary Research Compounds
-
Thymosin Beta 4 (Fragment 1-4) (60 Capsules) – N-Terminal Peptide Research
-
DSIP Delta Sleep-Inducing Peptide – Neuropeptide Research
-
TB-500 Fragment 17-23 – Targeted Actin-Binding Peptide Research
-
Thymosin Alpha 1 RGDR – Immunomodulatory Peptide Research
For comprehensive physicochemical and structural data, please consult the NCBI PubChem database.
Keywords: CJC-1295 no DAC for research, buy GHRH analogues, somatotropic research reagents, laboratory peptide supplies, endocrine research compounds.
Important Notice: All products, including CJC-1295 no DAC (Mod GRF 1-29), are supplied exclusively for in-vitro laboratory research and educational purposes. These products are not intended for human consumption, clinical applications, diagnostic use, or therapeutic intervention.
